Halbert Hargrove Global Advisors, LLC Johnson & Johnson Transaction History

Halbert Hargrove Global Advisors, LLC

$1.72 Billion
Q2 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 25, 2023	SELL	$151.05 - $180.26 $61,326 - $73,185	-406 Reduced 6.97%	5,417 $839,000
Q4 2022 Jan 25, 2023	SELL	$160.2 - $179.79 $43,093 - $48,363	-269 Reduced 4.42%	5,823 $0
Q3 2022 Oct 24, 2022	BUY	$161.33 - $179.52 $12,583 - $14,002	78 Added 1.3%	6,092 $995,000
Q2 2022 Aug 05, 2022	SELL	$168.19 - $186.01 $53,988 - $59,709	-321 Reduced 5.07%	6,014 $1.07 Million
Q1 2022 May 13, 2022	SELL	$158.14 - $179.59 $70,056 - $79,558	-443 Reduced 6.54%	6,335 $1.12 Million
Q4 2021 Feb 14, 2022	SELL	$155.93 - $173.01 $17,620 - $19,550	-113 Reduced 1.64%	6,778 $1.16 Million
Q3 2021 Oct 29, 2021	SELL	$161.5 - $179.47 $16,796 - $18,664	-104 Reduced 1.49%	6,891 $1.11 Million
Q2 2021 Jul 29, 2021	BUY	$159.48 - $171.07 $52,947 - $56,795	332 Added 4.98%	6,995 $1.15 Million
Q1 2021 May 06, 2021	BUY	$153.07 - $170.48 $13,776 - $15,343	90 Added 1.37%	6,663 $1.1 Million
Q4 2020 Feb 04, 2021	BUY	$137.11 - $157.38 $428,605 - $491,969	3,126 Added 90.69%	6,573 $1.04 Million
Q3 2020 Nov 10, 2020	BUY	$140.38 - $153.83 $53,204 - $58,301	379 Added 12.35%	3,447 $514,000
Q2 2020 Aug 10, 2020	SELL	$128.81 - $155.51 $1,030 - $1,244	-8 Reduced 0.26%	3,068 $432,000
Q1 2020 May 01, 2020	BUY	$111.14 - $153.99 $20,449 - $28,334	184 Added 6.36%	3,076 $404,000
Q4 2019 Feb 12, 2020	SELL	$127.5 - $146.44 $311,865 - $358,192	-2,446 Reduced 45.82%	2,892 $421,000
Q3 2019 Nov 12, 2019	BUY	$126.95 - $142.14 $258,343 - $289,254	2,035 Added 61.61%	5,338 $691,000
Q2 2019 Jul 26, 2019	BUY	$131.15 - $144.24 $433,188 - $476,424	3,303 New	3,303 $460,000
Q1 2019 May 13, 2019	SELL	$125.72 - $139.79 $413,367 - $459,629	-3,288 Closed	0 $0
Q4 2018 Feb 11, 2019	SELL	$122.84 - $147.84 $158,340 - $190,565	-1,289 Reduced 28.16%	3,288 $424,000
Q3 2018 Oct 31, 2018	BUY	$121.58 - $142.88 $164,011 - $192,745	1,349 Added 41.79%	4,577 $632,000
Q2 2018 Aug 10, 2018	BUY	$119.4 - $131.76 $2,746 - $3,030	23 Added 0.72%	3,228 $392,000
Q1 2018 May 01, 2018	SELL	$125.1 - $148.14 $16,763 - $19,850	-134 Reduced 4.01%	3,205 $411,000
Q4 2017 Feb 01, 2018	SELL	$131.22 - $143.62 $14,040 - $15,367	-107 Reduced 3.11%	3,339 $467,000
Q3 2017 Nov 02, 2017	BUY	$129.47 - $135.38 $446,153 - $466,519	3,446	3,446 $448,000

Others Institutions Holding JNJ

# of Institutions

4,161

Shares Held

1.69B

Call Options Held

12.5M

Put Options Held

10.3M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $431B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Halbert Hargrove Global Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Halbert Hargrove Global Advisors, LLC with notifications on news.

Account